BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 16438981)

  • 1. Myocardial homing and neovascularization by human bone marrow angioblasts is regulated by IL-8/Gro CXC chemokines.
    Kocher AA; Schuster MD; Bonaros N; Lietz K; Xiang G; Martens TP; Kurlansky PA; Sondermeijer H; Witkowski P; Boyle A; Homma S; Wang SF; Itescu S
    J Mol Cell Cardiol; 2006 Apr; 40(4):455-64. PubMed ID: 16438981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-8: a new player in the homing of endothelial progenitor cells to ischemic myocardium.
    Chavakis E
    J Mol Cell Cardiol; 2006 Apr; 40(4):442-5. PubMed ID: 16516915
    [No Abstract]   [Full Text] [Related]  

  • 3. CCR3- and CXCR4-mediated interactions regulate migration of CD34+ human bone marrow progenitors to ischemic myocardium and subsequent tissue repair.
    Bonaros N; Sondermeijer H; Schuster M; Rauf R; Wang SF; Seki T; Skerrett D; Itescu S; Kocher AA
    J Thorac Cardiovasc Surg; 2008 Oct; 136(4):1044-53. PubMed ID: 18954648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of the CXC chemokine receptor 4/stromal cell-derived factor 1 pathway enhances myocardial neovascularization, cardiomyocyte survival, and functional recovery after myocardial infarction.
    Bonaros N; Sondermeijer H; Wiedemann D; Schlechta B; Schachner T; Schuster M; Seki T; Martens TP; Itescu S; Kocher AA
    J Thorac Cardiovasc Surg; 2011 Sep; 142(3):687-96, 696.e1-2. PubMed ID: 21388641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function.
    Kocher AA; Schuster MD; Szabolcs MJ; Takuma S; Burkhoff D; Wang J; Homma S; Edwards NM; Itescu S
    Nat Med; 2001 Apr; 7(4):430-6. PubMed ID: 11283669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial neovascularization by adult bone marrow-derived angioblasts: strategies for improvement of cardiomyocyte function.
    Itescu S; Kocher AA; Schuster MD
    Ann Hematol; 2002; 81 Suppl 2():S21-5. PubMed ID: 12611063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caveolin plays a central role in endothelial progenitor cell mobilization and homing in SDF-1-driven postischemic vasculogenesis.
    Sbaa E; Dewever J; Martinive P; Bouzin C; Frérart F; Balligand JL; Dessy C; Feron O
    Circ Res; 2006 May; 98(9):1219-27. PubMed ID: 16601228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes.
    Aghi M; Cohen KS; Klein RJ; Scadden DT; Chiocca EA
    Cancer Res; 2006 Sep; 66(18):9054-64. PubMed ID: 16982747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of cardiac function with progenitor cells.
    Urbich C; Rössig L; Dimmeler S
    Novartis Found Symp; 2006; 274():214-23; discussion 223-7, 272-6. PubMed ID: 17019814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells.
    Huang PH; Chen YH; Wang CH; Chen JS; Tsai HY; Lin FY; Lo WY; Wu TC; Sata M; Chen JW; Lin SJ
    Arterioscler Thromb Vasc Biol; 2009 Aug; 29(8):1179-84. PubMed ID: 19461050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue.
    Ceradini DJ; Gurtner GC
    Trends Cardiovasc Med; 2005 Feb; 15(2):57-63. PubMed ID: 15885571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neovasculogenic therapy to augment perfusion and preserve viability in ischemic cardiomyopathy.
    Atluri P; Liao GP; Panlilio CM; Hsu VM; Leskowitz MJ; Morine KJ; Cohen JE; Berry MF; Suarez EE; Murphy DA; Lee WM; Gardner TJ; Sweeney HL; Woo YJ
    Ann Thorac Surg; 2006 May; 81(5):1728-36. PubMed ID: 16631663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fracture induced mobilization and incorporation of bone marrow-derived endothelial progenitor cells for bone healing.
    Matsumoto T; Mifune Y; Kawamoto A; Kuroda R; Shoji T; Iwasaki H; Suzuki T; Oyamada A; Horii M; Yokoyama A; Nishimura H; Lee SY; Miwa M; Doita M; Kurosaka M; Asahara T
    J Cell Physiol; 2008 Apr; 215(1):234-42. PubMed ID: 18205179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Akt is a key modulator of endothelial progenitor cell trafficking in ischemic muscle.
    Hur J; Yoon CH; Lee CS; Kim TY; Oh IY; Park KW; Kim JH; Lee HS; Kang HJ; Chae IH; Oh BH; Park YB; Kim HS
    Stem Cells; 2007 Jul; 25(7):1769-78. PubMed ID: 17412896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regenerative therapy for stroke.
    Chang YC; Shyu WC; Lin SZ; Li H
    Cell Transplant; 2007; 16(2):171-81. PubMed ID: 17474298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction.
    Hamada H; Kim MK; Iwakura A; Ii M; Thorne T; Qin G; Asai J; Tsutsumi Y; Sekiguchi H; Silver M; Wecker A; Bord E; Zhu Y; Kishore R; Losordo DW
    Circulation; 2006 Nov; 114(21):2261-70. PubMed ID: 17088460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LFA-1 and VLA-4 involved in human high proliferative potential-endothelial progenitor cells homing to ischemic tissue.
    Duan H; Cheng L; Sun X; Wu Y; Hu L; Wang J; Zhao H; Lu G
    Thromb Haemost; 2006 Dec; 96(6):807-15. PubMed ID: 17139377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial progenitor cells as a new agent contributing to vascular repair.
    Miller-Kasprzak E; Jagodziński PP
    Arch Immunol Ther Exp (Warsz); 2007; 55(4):247-59. PubMed ID: 17659378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis.
    Cipriani P; Guiducci S; Miniati I; Cinelli M; Urbani S; Marrelli A; Dolo V; Pavan A; Saccardi R; Tyndall A; Giacomelli R; Cerinic MM
    Arthritis Rheum; 2007 Jun; 56(6):1994-2004. PubMed ID: 17530639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating bone marrow-derived endothelial progenitor cells: characterization, mobilization, and therapeutic considerations in malignant disease.
    Dome B; Dobos J; Tovari J; Paku S; Kovacs G; Ostoros G; Timar J
    Cytometry A; 2008 Mar; 73(3):186-93. PubMed ID: 18000872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.